» Articles » PMID: 26869418

Characterization of Sizes of Aggregates of Insulin Analogs and the Conformations of the Constituent Protein Molecules: A Concomitant Dynamic Light Scattering and Raman Spectroscopy Study

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 2016 Feb 13
PMID 26869418
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

To generate aggregates, 3 insulin analogs, lispro, aspart, and glulisine, were incubated without phenolic preservatives for 30 days at 37 °C. As a function of incubation time, aggregation was quantified with size exclusion chromatography, and the sizes of aggregates and the conformations of the constituent molecules were characterized with concomitant dynamic light scattering and Raman spectroscopy. During incubation, lispro was progressively converted into soluble aggregates with hydrodynamic diameters of circa 15 nm, and 95% of the native protein had aggregated at day 30. Raman spectroscopy documented that aggregation resulted in conversion of a large fraction of native alpha helix into nonnative beta sheet structure and a distortion of disulfide bonds. In contrast, for aspart and glulisine only 20% of the native proteins aggregated after 30 days, and minimal structural perturbations were detected. In addition, consistent with the relative aggregation rates during isothermal incubation, Raman spectroscopy showed that during heating the onset temperature for secondary structural perturbations of lispro occurred 7 °C-10 °C lower than those for aspart or glulisine. Overall the results of this study demonstrated that-as in the case during formation of amyloid fibrils from insulin-formation of soluble aggregates of lispro resulted in a high level of conversion of alpha helix into beta sheet.

Citing Articles

Comparative physicochemical and structural characterisation studies establish high biosimilarity between BGL-ASP and reference insulin aspart.

Ghade N, Thappa D, Lona J, Krishnan A, Sonar S Sci Rep. 2024; 14(1):4224.

PMID: 38378730 PMC: 10879530. DOI: 10.1038/s41598-024-54819-x.


SAXS Reveals the Stabilization Effects of Modified Sugars on Model Proteins.

Piccinini A, Lourenco E, Ascenso O, Ventura M, Amenitsch H, Moretti P Life (Basel). 2022; 12(1).

PMID: 35054516 PMC: 8778440. DOI: 10.3390/life12010123.


Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia.

Mulka A, Lewis B, Mao L, Sharafieh R, Kesserwan S, Wu R ACS Pharmacol Transl Sci. 2021; 4(3):1161-1174.

PMID: 34151206 PMC: 8205237. DOI: 10.1021/acsptsci.1c00047.


Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping.

Mukherjee M, Das D, Sarkar J, Banerjee N, Jana J, Bhat J iScience. 2021; 24(6):102573.

PMID: 34142060 PMC: 8184657. DOI: 10.1016/j.isci.2021.102573.


Inspecting Insulin Products Using Water Proton NMR. I. Noninvasive vs Invasive Inspection.

Taraban M, Wang Y, Briggs K, Yu Y J Diabetes Sci Technol. 2021; 16(6):1410-1418.

PMID: 34111968 PMC: 9631543. DOI: 10.1177/19322968211023806.